Right on!
The only downside in that regard is the huge R&D spending they are doing, but they are developing products in 3 different industries, so that is to be expected.
MEDICAL
They are always looking to improve their medical offering, and their work to date has paid off which is evidenced by the only company with an approved exoskeleton designed for stroke patients as well as a huge range of spinal cord injuries. I believe the closest competitor is only approved for rehab of injuries to a couple vertebrae. EKSOD is nearly the entire spine!
INDUSTRIAL
They have created a device to help construction workers lower injuries and fatigue from handling heavy tools for long periods of time. This is just getting off the ground, but they already have a 25 unit test deal with United Rentals for demonstration purposes and to increase awareness. As a member of the construction industry, I think this is a fantastic device, but due to the large upfront cost, it is much better suited as a rental unit to start with. Once a company looks at it's books and realizes how much they are renting it, they can do a cost comparison for themselves and argue for a purchase.
MILITARY
With repeated DARPA contracts under their belt already, they should remain a mainstay of the TALOS program for years to come.
I bought at a bad time last year, and am sitting on roughly a 40% loss compared to current SP levels, but I have utmost faith in this company and their CEO Thomas Looby. Once we are uplisted this should make a steady climb to at least $10-12 on the conservative site. If I had more dry powder to average down right now, I certainly would!
